Gene variants tied to increased risk of severe COVID-19 disease

October 15, 2020 – SARS-CoV-2 and its resulting disease, Covid-19 disease, is (still) rattling the world. It still remains largely unknown, at this point in time, which are the infected individuals who fall very seriously, even fatally, ill with Covid-19 disease. Of course, there seem to exist some given risk factors, such as age, gender, pre-existing disease, etc. However, there are infected individuals (i.e., patients) who fulfil all these predisposing factors, but don’t even fall ill or easily recover from the infection by SARS-CoV-2  and/or the symptoms of Covid-19 disease.

How come? Researchers think that there may exist genetic variations that render one patient more vulnerable to i) infection as such, and ii) the course and the severity of the Covid-19 disease in a infected individual. In fact, some recent studies point in these direction. Thus, very recently, according to a Science report, researchers have tied three common gene variants to increased risk of severe COVID-19. In this study, a University of Edinburgh-led team conducted a genome-wide association analysis of more than 2,000 patients with severe COVID-19. As they report in a preprint posted to MedRxiv, the researchers homed in on three loci: one within the DPP9 gene, which encodes dipeptidyl peptidase 9, one within a gene cluster encoding the antiviral restriction enzyme activators OAS1, OAS2, and OAS3, and one in the interferon receptor gene IFNAR2.

Science notes that the IFNAR2 variant the team uncovered is present in about a quarter of Europeans and raises the risk of severe disease by 30 percent. This finding is in line with a recent study which showed that clinical outcome upon infection with SARS-CoV-2 ranges from silent infection to lethal Covid-19, and that in these severe cases an enrichment in rare variants predicted to be loss-of-function (LOF) at the 13 human loci known to govern TLR3– and IRF7-dependent type I interferon (IFN) immunity to influenza virus, in 659 patients with life-threatening Covid-19 pneumonia, relative to 534 subjects with asymptomatic or benign infection was found. By testing these and other rare variants at these 13 loci, LOF variants in 23 patients (3.5%), aged 17 to 77 years, underlying autosomal recessive or dominant deficiencies were experimentally defined. Human fibroblasts with mutations affecting this pathway were shown to be vulnerable to SARS-CoV-2. Thus, inborn errors of TLR3- and IRF7-dependent type I IFN immunity can underlie life-threatening COVID-19 pneumonia in patients with no prior severe infection.

Overall, the findings from both of these studies suggest that rare mutations in interferon genes like IFNAR2 are associated with severe disease and that seemingly a considerable proportion of Europeans (i.e., people of Caucasian descent) may carry such defects, leaving them vulnerable to severe courses of the Covid-19 disease.

Surprising in the present study is certainly the finding that the OAS gene may be involved in severe Covid-19 disease predisposition as the OAS genes encode proteins that activate enzymes that typically break down viral genomes. This means that some people are left more vulnerable to initial virus attacks than others. Whether this applies to attacks by SARS-CoV-2 only, or more general to attacks by any virus remains an open question.

Besides, previous studies have also implicated regions on chromosome 3 and in the ABO blood locus. Overall, these studies help to slowly understand more profoundly the impact of SARS-CoV-2 may have on a given individual, and, in the long run, may also help to tailor anti-viral and/or anti-disease treatments more precisely.

See here a sequence on genetics and susceptibility (predisposition) for Covid-19:

Print Friendly, PDF & Email

Tags: , , , , , , , , , , , , ,
About the Author
Joseph Gut - thasso Ph.D.; Professor in Pharmacology and Toxicology. Senior expert in theragenomic and personalized medicine and individualized drug safety. Senior expert in pharmaco- and toxicogenetics. Senior expert in human safety of drugs, chemicals, environmental pollutants, and dietary ingredients.

Your opinion


No comments yet

thasso: conditions

thasso: newest tweets

thasso: recent comments

View my Flipboard Magazine.

thasso: categories

thasso: archives

thasso: simple chat

You must be a registered user to participate in this chat.

  • BICRA gene provides answers to patients, doctors and scientists November 23, 2020
    Physicians and scientists are constantly on the lookout for new disease genes that can help them understand why patients have undiagnosed medical problems. Often the first clues come from genetic testing that reveals a change or mutation in a gene that they see in a child but not their parents. This is exactly what led […]
  • New targeted therapy blocks metabolism in brain cancer cells with genetic vulnerability November 23, 2020
    Researchers at The University of Texas MD Anderson Cancer Center have developed a novel targeted therapy, called POMHEX, which blocks critical metabolic pathways in cancer cells with specific genetic defects. Preclinical studies found the small-molecule enolase inhibitor to be effective in killing brain cancer cells that were missing ENO1, one of two genes encoding the […]
  • Major new study unveils complexity and vast diversity of Africa's genetic variation November 23, 2020
    Africa is the cradle of humankind. All humans are descendants from this common pool of ancestors. Africa and its multitude of ethnolinguistic groups are therefore fundamental to learning more about humankind and our origins.
  • Targeting drug-resistant cancers through mathematical biology to control gene expression November 23, 2020
    Among the things to give thanks for this year is the fact that stubborn, persistent problems seem to have an irresistible sort of magnetic pull for scientists and mathematicians. Things that would leave most of us bewildered are their daily bread.
  • Study finds hyperbaric oxygen treatments reverse aging process November 20, 2020
    A new study from Tel Aviv University (TAU) and the Shamir Medical Center in Israel indicates that hyperbaric oxygen treatments (HBOT) in healthy aging adults can stop the aging of blood cells and reverse the aging process. In the biological sense, the adults' blood cells actually grow younger as the treatments progress.
  • Creating higher energy density lithium-ion batteries for renewable energy applications November 24, 2020
    Lithium-ion batteries that function as high-performance power sources for renewable applications, such as electric vehicles and consumer electronics, require electrodes that deliver high energy density without compromising cell lifetimes. In the Journal of Vacuum Science and Technology A, researchers investigate the origins of degradation in high energy density LIB cathode materials and develop strategies for […]
  • Cocoa flavanols boost brain oxygenation, cognition in healthy adults November 24, 2020
    The brains of healthy adults recovered faster from a mild vascular challenge and performed better on complex tests if the participants consumed cocoa flavanols beforehand, researchers report in the journal Scientific Reports. In the study, 14 of 18 participants saw these improvements after ingesting the flavanols.
  • Which speaker are you listening to? Hearing aid of the future uses brainwaves to find out November 24, 2020
    In a noisy room with many speakers, hearing aids can suppress background noise, but they have difficulties isolating one voice - that of the person you're talking to at a party, for instance. Researchers at KU Leuven, Belgium, have now addressed that issue with a technique that uses brainwaves to determine within one second whom […]
  • New therapy for flu may help in fight against COVID-19 November 24, 2020
    A new therapy for influenza virus infections that may also prove effective against many other pathogenic virus infections, including HIV and COVID-19, has been developed by Purdue University scientists. The Purdue team's approach uses a targeted therapy approach against the virus infections.
  • Sound waves power new advances in drug delivery and smart materials November 24, 2020
    Sound waves have been part of science and medicine for decades, but the technologies have always relied on low frequencies. Now researchers have revealed how high frequency sound waves could revolutionise the field of ultrasound-driven chemistry.